Haemonetics (HAE) Net Margin Growth (3y) (2012 - 2026)

Haemonetics (HAE) Net Margin Growth (3y) (2012 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin Growth (3y) (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn -388.00
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn -1.00
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn -315.00
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 1,692.00
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 2.00
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn 1,018.00
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 399.00
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn -
10 Haemonetics 3.50 Bn 3.25 Bn 198.21 Mn -1,548.00

Historic Data

Download Data
DateValue
Mar 28, 2026 -1,548.00
Dec 27, 2025 242.00
Sep 27, 2025 66.00
Jun 28, 2025 299.00
Mar 29, 2025 1,385.00
Dec 28, 2024 183.00
Sep 28, 2024 360.00
Jun 29, 2024 1,338.00
Mar 30, 2024 1,085.00
Dec 30, 2023 -397.00
Sep 30, 2023 -1,510.00
Jul 1, 2023 782.00
Apr 1, 2023 227.00
Dec 31, 2022 -75.00
Oct 1, 2022 -368.00
Jul 2, 2022 1,118.00
Apr 2, 2022 -467.00
Jan 1, 2022 154.00
Oct 2, 2021 -156.00
Jul 3, 2021 -73.00